IT1274351B - Uso di alcuni glicosaminoglicani nella dialisi peritoneale. - Google Patents

Uso di alcuni glicosaminoglicani nella dialisi peritoneale.

Info

Publication number
IT1274351B
IT1274351B ITBO940436A ITBO940436A IT1274351B IT 1274351 B IT1274351 B IT 1274351B IT BO940436 A ITBO940436 A IT BO940436A IT BO940436 A ITBO940436 A IT BO940436A IT 1274351 B IT1274351 B IT 1274351B
Authority
IT
Italy
Prior art keywords
peritoneal
sulodexide
subjected
molecular weight
low molecular
Prior art date
Application number
ITBO940436A
Other languages
English (en)
Inventor
Bruno Baggio
Giorgio Bazzato
Agostino Fracasso
Giovanni Gambaro
Egidio Marchi
Gianfranco Tamagnone
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Publication of ITBO940436A0 publication Critical patent/ITBO940436A0/it
Priority to ITBO940436A priority Critical patent/IT1274351B/it
Priority to PT95113868T priority patent/PT710483E/pt
Priority to EP95113868A priority patent/EP0710483B1/en
Priority to DE69521388T priority patent/DE69521388T2/de
Priority to ES95113868T priority patent/ES2157277T3/es
Priority to AT95113868T priority patent/ATE202282T1/de
Priority to DK95113868T priority patent/DK0710483T3/da
Priority to US08/530,597 priority patent/US5686432A/en
Publication of ITBO940436A1 publication Critical patent/ITBO940436A1/it
Application granted granted Critical
Publication of IT1274351B publication Critical patent/IT1274351B/it
Priority to GR20010401009T priority patent/GR3036158T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
ITBO940436A 1994-10-06 1994-10-06 Uso di alcuni glicosaminoglicani nella dialisi peritoneale. IT1274351B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ITBO940436A IT1274351B (it) 1994-10-06 1994-10-06 Uso di alcuni glicosaminoglicani nella dialisi peritoneale.
ES95113868T ES2157277T3 (es) 1994-10-06 1995-09-04 Uso de glucosaminoglucanos para la fabricacion de un medicamento para el tratamiento de insuficiencia renal cronica.
EP95113868A EP0710483B1 (en) 1994-10-06 1995-09-04 Use of some glycosaminoglycans for the manufacture of a medicament for the treatment of chronic renal failure
DE69521388T DE69521388T2 (de) 1994-10-06 1995-09-04 Verwendung von Glycosaminoglycanen zur Herstellung eines Arzneimittels zur Behandlung des chronischen Nierenversagens
PT95113868T PT710483E (pt) 1994-10-06 1995-09-04 Utilizacao de alguns glicosaminoglicanos para a producao de um medicamento para o tratamento da insuficiencia renal cronica
AT95113868T ATE202282T1 (de) 1994-10-06 1995-09-04 Verwendung von glycosaminoglycanen zur herstellung eines arzneimittels zur behandlung des chronischen nierenversagens
DK95113868T DK0710483T3 (da) 1994-10-06 1995-09-04 Anvendelse af visse glycosaminoglycaner til fremstillingen af et lægemiddel til behandlingen af kronisk nyresvigt
US08/530,597 US5686432A (en) 1994-10-06 1995-09-19 Use of some glycosaminoglycans in the peritoneal dialysis
GR20010401009T GR3036158T3 (en) 1994-10-06 2001-06-29 Use of some glycosaminoglycans for the manufacture of a medicament for the treatment of chronic renal failure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO940436A IT1274351B (it) 1994-10-06 1994-10-06 Uso di alcuni glicosaminoglicani nella dialisi peritoneale.

Publications (3)

Publication Number Publication Date
ITBO940436A0 ITBO940436A0 (it) 1994-10-06
ITBO940436A1 ITBO940436A1 (it) 1996-04-06
IT1274351B true IT1274351B (it) 1997-07-17

Family

ID=11340040

Family Applications (1)

Application Number Title Priority Date Filing Date
ITBO940436A IT1274351B (it) 1994-10-06 1994-10-06 Uso di alcuni glicosaminoglicani nella dialisi peritoneale.

Country Status (9)

Country Link
US (1) US5686432A (it)
EP (1) EP0710483B1 (it)
AT (1) ATE202282T1 (it)
DE (1) DE69521388T2 (it)
DK (1) DK0710483T3 (it)
ES (1) ES2157277T3 (it)
GR (1) GR3036158T3 (it)
IT (1) IT1274351B (it)
PT (1) PT710483E (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127896A0 (en) * 1998-12-31 1999-10-28 Gail Laster A novel treatment for preeclampsia and related diseases
AU782661B2 (en) * 1999-06-30 2005-08-18 Hamilton Civic Hospitals Research Development, Inc. Heparin compositions that inhibit clot associated coagulation factors
ITMI991503A1 (it) * 1999-07-08 2001-01-08 Bidifarm S R L Uso di metaboliti oligosaccaridici di proteoglicani come maker in fluidi biologici di diagnosi del biabete e delle complicanze patologiche c
US7259152B2 (en) * 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
CZ2003961A3 (cs) * 2000-09-08 2003-10-15 Hamilton Civic Hospitals Research Development, Inc. Farmaceutický prostředek k inhibici nebo prevenci tvorby či aktivity thrombinu
US20030008844A1 (en) * 2001-05-17 2003-01-09 Keryx Biopharmaceuticals, Inc. Use of sulodexide for the treatment of inflammatory bowel disease
JP2004533463A (ja) * 2001-06-12 2004-11-04 ケリクス・バイオフアーマシユーチカルズ・インコーポレーテツド 腎症の治療のためのグリコサミノグリカンの使用方法
PE20030263A1 (es) * 2001-07-31 2003-04-17 Novartis Ag Composicion farmaceutica oftalmica
EP1890686B1 (en) 2005-05-30 2017-10-04 Fresenius Medical Care Deutschland GmbH Peritoneal dialysis fluid
CA2634871A1 (en) 2005-12-22 2007-11-08 Neurochem (International) Limited Treatment of renal disorders, diabetic nephopathy and dyslipidemias
US20070155672A1 (en) * 2006-01-05 2007-07-05 Markus Voges Sterilized peritoneal dialysis solutions containing heparin
CN101883794B (zh) 2007-10-01 2012-11-07 生化学工业株式会社 低分子化硫酸软骨素及其用途
CN101632686A (zh) * 2008-04-04 2010-01-27 马斯特里赫特大学 糖胺聚糖用于修复糖萼的用途
IT1401253B1 (it) * 2010-04-23 2013-07-18 Uni Degli Studi Carlo Bo Urbino Uso del sulodexide per la riduzione delle metalloproteinasi di matrice.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245907B (it) * 1991-05-17 1994-10-25 Alfa Wassermann Spa Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica.
IT1270846B (it) * 1993-05-10 1997-05-13 Alfa Wassermann Spa Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica.
US5801162A (en) * 1993-09-30 1998-09-01 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Dermatan sulfate compositions and antithrombotic compositions containing same

Also Published As

Publication number Publication date
EP0710483A1 (en) 1996-05-08
ITBO940436A1 (it) 1996-04-06
ATE202282T1 (de) 2001-07-15
GR3036158T3 (en) 2001-09-28
DE69521388D1 (de) 2001-07-26
DK0710483T3 (da) 2001-09-03
DE69521388T2 (de) 2001-10-11
ITBO940436A0 (it) 1994-10-06
EP0710483B1 (en) 2001-06-20
US5686432A (en) 1997-11-11
PT710483E (pt) 2001-09-28
ES2157277T3 (es) 2001-08-16

Similar Documents

Publication Publication Date Title
IT1274351B (it) Uso di alcuni glicosaminoglicani nella dialisi peritoneale.
Taylor et al. Erythropoietin and spontaneous platelet aggregation in haemodialysis patients
DE68913557D1 (de) Peritonealdialyse-katheter.
DE69422609T2 (de) Faltbarer katheter für peritoneale dialyse
DE59304193D1 (de) Dialyselösung für die Peritonealdialyse
IT9067168A0 (it) Apparecchiatura per la depurazione del sangue, particolarmente per il trattamento di pazienti affetti da insufficienza renale, e procedimentoo per produzione di liquido di reinfusione per emodiafiltrazione (hdf)
Khan et al. Hypokalemia in peritoneal dialysis patients
von Lilien et al. Five years' experience with continuous ambulatory or continuous cycling peritoneal dialysis in children
Hory et al. Continuous arteriovenous hemofiltration with low-molecular-weight heparin
Gross et al. Ceftizoxime elimination kinetics in continuous ambulatory peritoneal dialysis
Koup et al. Ceftriaxone pharmacokinetics during peritoneal dialysis
O'Regan et al. Hemolytic uremic syndrome: urate nephropathy superimposed on an acute glomerulopathy? An hypothesis
Wise et al. The pharmacokinetics of cefotaxime and ceftriaxone in renal and hepatic dysfunction
Brown et al. Peritoneal clearance of theophylline
Nensel et al. Dialyzer permeability for low-molecular-weight proteins: comparison between polysulfone, polyamide and cuprammonium-rayon dialyzers
Haag-Weber et al. Neutrophil activation during hemodialysis
LEE et al. Clinical Significances of Scrum Protein C and S in Chronic Renal Failure
Byung-Jin et al. Effect of Erythropoietin on Dialyzer Reuse, Dialysis Efficacy and Other Clinical Parameters
Aberger et al. Differences in drug removal between standard high-flux and medium cut-off dialyzers in a case of severe vancomycin toxicity
Janknegt et al. Drug therapy in continuous ambulatory peritoneal dialysis patients
Trafford et al. The use of hemoperfusion as an adjunct to hemodialysis
Usama Serum haptoglobin in chronic renal failure patients
Churchill Adequacy of Peritoneal Dialysis: Research Needs.
Katayama Comparison of continuous renal replacement therapy by clearance measurement
KIM et al. Introduction of a New Therapeutic Modality for the Chronic Behcets Disease Patients: Synchronization of Plasmapheresis with Immune Modulation Therapy

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970716